Abstract:The activity of SERCA was significantly decreased in NAc after METH‐CPP. Intraperitoneal SERCA agonist CDN1163 injection or bilateral CDN1163 microinjection in the NAc inhibited METH‐CPP formation. SERCA2b overexpression by the Adeno‐associated virus can reduce the DA release of NAc and inhibit METH‐CPP formation. Interference with SERCA2b expression in NAc by adeno‐associated virus increased DA release and promoted METH‐CPP formation. METH reduced the SERCA ability to transport Ca2+ into the ER in SHSY5Y cells in vitro, which was reversed by CDN1163. Methamphetamine (METH) is a highly addictive psycho‐stimulant that induces addictive behaviour by stimulating increased dopamine release in the nucleus accumbens (NAc). The sarco/endoplasmic reticulum calcium ion transport ATPases (SERCA or ATP2A) is a calcium ion (Ca2+) pump in the endoplasmic reticulum (ER) membrane. SERCA2b is a SERCA subtype mainly distributed in the central nervous system. This study used conditioned place preference (CPP), a translational drug reward model, to observe the effects of SERCA and SERCA2b on METH‐CPP in mice. Result suggested that the activity of SERCA was significantly decreased in NAc after METH‐CPP. Intraperitoneal SERCA agonist CDN1163 injection or bilateral CDN1163 microinjection in the NAc inhibited METH‐CPP formation. SERCA2b overexpression by the Adeno‐associated virus can reduce the DA release of NAc and inhibit METH‐CPP formation. Although microinjection of SERCA inhibitor thapsigargin in the bilateral NAc did not significantly aggravate METH‐CPP, interference with SERCA2b expression in NAc by adeno‐associated virus increased DA release and promoted METH‐CPP formation. METH reduced the SERCA ability to transport Ca2+ into the ER in SHSY5Y cells in vitro, which was reversed by CDN1163. This study revealed that METH dysregulates intracellular calcium balance by downregulating SERCA2b function, increasing DA release in NAc and inducing METH‐CPP formation. Drugs that target SERCA2b may have the potential to treat METH addiction.

Syvn1, An Erad E3 Ubiquitin Ligase, Is Involved In Gaba(A)Alpha 1 Degradation Associated With Methamphetamine-Induced Conditioned Place Preference

Glycogen Synthase Kinase 3 Beta In The Nucleus Accumbens Core Is Critical For Methamphetamine-Induced Behavioral Sensitization

Role of GSK3β/α-synuclein Axis in Methamphetamine-Induced Neurotoxicity in PC12 Cells

Transfer of Α-Synuclein from Neurons to Oligodendrocytes Triggers Myelin Sheath Destruction in Methamphetamine Administration Mice.

Psilocin Suppresses Methamphetamine‐induced Hyperlocomotion and Acquisition of Conditioned Place Preference Via D2R‐mediated ERK Signaling

Involvement of dorsal striatal α1-containing GABAA receptors in methamphetamine-associated rewarding memories

The role of heterodimers formed by histamine H3 receptors and dopamine D1 receptors on the methamphetamine-induced conditioned place preference

Targeting Aβ and P-Tau Clearance in Methamphetamine-Induced Alzheimer's Disease-Like Pathology: Roles of Syntaxin 17 in Autophagic Degradation in Primary Hippocampal Neurons.

Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens.

p-Nrf2/HO-1 Pathway Involved in Methamphetamine-induced Executive Dysfunction through Endoplasmic Reticulum Stress and Apoptosis in the Dorsal Striatum

LY235959 attenuates development phase of Methamphetamine-Induced behavioral sensitization through the PP2A/B - AKT cascade in the dorsal striatum of C57/BL6 mice

The Roles of K+-dependent Na+/Ca2+ Exchanger 2 (NCKX2) in Methamphetamine-Induced Behavioral Sensitization and Conditioned Place Preference in Mice.

LASP1 in the nucleus accumbens modulates methamphetamine-induced conditioned place preference in mice

Involvement of nucleus accumbens SERCA2b in methamphetamine‐induced conditioned place preference

Neurotoxic Methamphetamine Doses Alter CDCel-1 Levels and Its Interaction with Vesicular Monoamine Transporter-2 in Rat Striatum

Targeting A β and p-Tau Clearance in Methamphetamine-Induced Alzheimer's Disease-Like Pathology: Roles of Syntaxin 17 in Autophagic Degradation in Primary Hippocampal Neurons

MicroRNA-181a Is Involved in Methamphetamine Addiction Through the ERAD Pathway

The Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity

PPARγ/Adiponectin axis attenuates methamphetamine-induced conditional place preference via the hippocampal AdipoR1 signaling pathway

Deletion of VGLUT2 in midbrain dopamine neurons attenuates dopamine and glutamate responses to methamphetamine in mice

CNTN1 in the Nucleus Accumbens is Involved in Methamphetamine-Induced Conditioned Place Preference in Mice